- Home
- MNKD vs LEU Comparison
MNKD vs LEU Comparison
Compare MNKD & LEU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNKD
- LEU
- Stock Information
- Founded
- MNKD 1991
- LEU 1998
- Country
- MNKD United States
- LEU United States
- Employees
- MNKD N/A
- LEU N/A
- Industry
- MNKD Biotechnology: Pharmaceutical Preparations
- LEU Mining & Quarrying of Nonmetallic Minerals (No Fuels)
- Sector
- MNKD Health Care
- LEU Industrials
- Exchange
- MNKD Nasdaq
- LEU Nasdaq
- Market Cap
- MNKD 1.6B
- LEU 1.3B
- IPO Year
- MNKD 2004
- LEU 1998
- Fundamental
- Price
- MNKD $5.03
- LEU $62.16
- Analyst Decision
- MNKD Buy
- LEU Buy
- Analyst Count
- MNKD 6
- LEU 4
- Target Price
- MNKD $8.92
- LEU $147.00
- AVG Volume (30 Days)
- MNKD 1.9M
- LEU 545.8K
- Earning Date
- MNKD 05-07-2025
- LEU 05-06-2025
- Dividend Yield
- MNKD N/A
- LEU N/A
- EPS Growth
- MNKD N/A
- LEU N/A
- EPS
- MNKD 0.10
- LEU 4.47
- Revenue
- MNKD $285,504,000.00
- LEU $442,000,000.00
- Revenue This Year
- MNKD $14.66
- LEU $2.45
- Revenue Next Year
- MNKD $14.27
- LEU $17.65
- P/E Ratio
- MNKD $50.50
- LEU $13.91
- Revenue Growth
- MNKD 43.50
- LEU 38.04
- 52 Week Low
- MNKD $3.97
- LEU $33.51
- 52 Week High
- MNKD $7.63
- LEU $122.95
- Technical
- Relative Strength Index (RSI)
- MNKD 37.28
- LEU 30.35
- Support Level
- MNKD $5.16
- LEU $71.88
- Resistance Level
- MNKD $5.12
- LEU $77.70
- Average True Range (ATR)
- MNKD 0.14
- LEU 4.17
- MACD
- MNKD 0.01
- LEU -0.83
- Stochastic Oscillator
- MNKD 25.45
- LEU 5.77
About MNKD MannKind Corporation
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.
About LEU Centrus Energy Corp.
Centrus Energy Corp is engaged in the supply of nuclear fuel and services for the nuclear power industry. It operates through the Low-Enriched Uranium (LEU) and Technical Solutions segments. The LEU segment has two components which include the sale of separative work units and uranium. The Technical Solutions segment provides engineering, design, and manufacturing services to government and private sector customers. The majority of the firm's revenue is derived from the LEU segment. It has a business presence in the U.S. and other countries, of which prime revenue is generated in the U.S.